Found: 10
Select item for more details and to access through your institution.
Outcomes following switching from etanercept originator to etanercept biosimilar in 1024 patients with RA: a matched-analysis of the BSRBR-RA.
- Published in:
- Rheumatology, 2024, v. 63, n. 8, p. 2082, doi. 10.1093/rheumatology/kead470
- By:
- Publication type:
- Article
Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying anti-rheumatic drugs: does line of therapy matter?
- Published in:
- Rheumatology, 2024, v. 63, n. 7, p. 1957, doi. 10.1093/rheumatology/kead515
- By:
- Publication type:
- Article
Socioeconomic deprivation is associated with reduced response and lower treatment persistence with TNF inhibitors in rheumatoid arthritis.
- Published in:
- Rheumatology, 2024, v. 63, n. 3, p. 648, doi. 10.1093/rheumatology/kead261
- By:
- Publication type:
- Article
Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA.
- Published in:
- Rheumatology, 2023, v. 62, n. 12, p. 3849, doi. 10.1093/rheumatology/kead127
- By:
- Publication type:
- Article
Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis.
- Published in:
- Rheumatology, 2022, v. 61, n. 12, p. 4678, doi. 10.1093/rheumatology/keac190
- By:
- Publication type:
- Article
Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA.
- Published in:
- Rheumatology, 2020, v. 59, n. 7, p. 1709, doi. 10.1093/rheumatology/kez518
- By:
- Publication type:
- Article
Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
- Published in:
- Rheumatology, 2020, v. 59, n. 3, p. 559, doi. 10.1093/rheumatology/kez277
- By:
- Publication type:
- Article
Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients.
- Published in:
- Rheumatology, 2019, v. 58, n. 12, p. 2162, doi. 10.1093/rheumatology/kez188
- By:
- Publication type:
- Article
Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
- Published in:
- Rheumatology, 2018, v. 57, n. 9, p. 1533, doi. 10.1093/rheumatology/kex304
- By:
- Publication type:
- Article
Long-term persistence with rituximab in patients with rheumatoid arthritis.
- Published in:
- Rheumatology, 2018, v. 57, n. 6, p. 1089, doi. 10.1093/rheumatology/key036
- By:
- Publication type:
- Article